Dr. Mercola's Censored Library (Private Membership)

Share this post
Ivermectin vs. Merck's New Antiviral, Molnupiravir
takecontrol.substack.com

Ivermectin vs. Merck's New Antiviral, Molnupiravir

Based on Merck's data, a comparison between molnupiravir and ivermectin yields interesting results. Consider other nonprescription strategies for prevention and early treatment.

Dr. Joseph Mercola
Oct 25, 2021
1
Share this post
Ivermectin vs. Merck's New Antiviral, Molnupiravir
takecontrol.substack.com

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2022 Dr. Joseph Mercola
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing